Cannabis Module: Epilepsy and Movement Disorders
2.0 hour online/home study education module
Over the past several years, there has been a growing interest in using medicinal cannabis to treat certain neurological conditions. Much debate has occurred over which cannabinoids may provide evidence-based or anecdotal relief for a variety of symptoms. In this module we will explore available literature and investigate real-world clinical use in epilepsy and movement disorders.
Learning Objectives
At the completion of this course, participants will be able to:
- Evaluate the evidence for cannabis use in patients with different types of epilepsy.
- Examine use and challenges of Epidiolex use in patients with epilepsy.
- Describe the evidence available for using cannabis in patients with movement disorders.
- Identify the potential future role for cannabis use in epilepsy and movement disorders.
The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). This event has been accredited for up to 2.0 contact hours of knowledge-based CPE home study.
0008-0000-22-075-H01-P
Release 08/18/2022
Expires 08/18/2025
Secure Online Registration
